Long-term transvenous cardiac pacing with chardack-greatbatch (medtronic) pacemaker

Abstract

Cardiac Pacemakers-Sowton EBLRn 13 (Johansson, 1966) while paced patients have a one-year mortality of only 10-15% (Chardack, 1967; Sowton, 1967) it seems likely that the number of paced patients in Britain will continue to increase rapidly. It is to be hoped that improvements in pacemaker design and manufacture will continue, and will be matched by an increasing standard of implantation and followup care.Summary and Conclusions A retrospective survey of all cardiac pacemakers sold over a 12-month period in Britain was carried out and an 81 % return achieved.Of the pacing systems which failed the cause was not the generator itself in 43 % of cases.About one in every three patients stopped pacing before the pacemaker was replaced.Attempts should be made to improve follow-up procedures for paced patients.Thanks are due to the suppliers of the pacemakers concerned and to the many physicians, surgeons, and technicians who completed and returned the very full questionary.

Implanted-pacemaker-induced dysrhythmia and its management

“…We do not follow this practice: we prefer to use an anti-dysrhythmic drug only when the dysrhythmia demands its use. Forbes et al (1968) treated the extra-systoles with either procainamide or quinidine. Procainamide has been shown to increase the threshold (Siddon & Sowton, 1968).…”

Displacement of pacemaker leads--a 10-year survey.

“…The usual procedure in Glasgow (Forbes et al, 1968) for placement of the lead tip has remained unchanged during the 10-year period of the survey. The data reported in this survey were extracted from the computer data bank used in Glasgow for storage of information on all pacemaker operations (Green and Reekie, 1975).…”